Sargramostim Use in COVID-19 to Recover Patient Health

Clinical trial NCT04707664 · COMPLETED

Trial details

NCT number: NCT04707664
Sponsor: Partner Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 SARS-CoV Infection

Start date: 2021-04-27
Primary completion: 2021-12-28
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.